Boston Scientific Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 8,050.0 | 8,357.0 | 7,821.0 |
| Cost of Goods Sold | 2,469.0 | 2,342.0 | 2,207.0 |
| Gross Profit | 5,581.0 | 6,015.0 | 5,614.0 |
| Gross Profit Margin | 69.3% | 72.0% | 71.8% |
| SG&A Expense | 2,589.0 | 2,909.0 | 2,675.0 |
| Depreciation & Amortization | 543.0 | 641.0 | 530.0 |
| Operating Income | (1,563.0) | 1.0 | (3,100.0) |
| Operating Margin | -- | 0.0% | -- |
| Nonoperating Income | (58.0) | 15.0 | (56.0) |
| Nonoperating Expenses | (468.0) | -- | -- |
| Income Before Taxes | (2,031.0) | (569.0) | (3,535.0) |
| Income Taxes | 5.0 | (74.0) | 42.0 |
| Net Income After Taxes | (2,036.0) | (495.0) | (3,577.0) |
| Continuing Operations | (2,036.0) | (495.0) | (3,577.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (2,036.0) | (495.0) | (3,577.0) |
| Total Net Income | (2,036.0) | (495.0) | (3,577.0) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.36) | (0.33) | (2.81) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
